カテゴリー： Market Monitor Global, 世界, 医療/バイオ

二重染色フローサイトメトリーの世界市場見通し2023年-2029年

◆英語タイトル：Dual Fluorescence Cytometry Viability Analyzer Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2285）

◆商品コード：MMG23FB2285
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：113
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の二重染色フローサイトメトリー市場規模と予測を収録しています。・世界の二重染色フローサイトメトリー市場：売上、2018年-2023年、2024年-2029年
・世界の二重染色フローサイトメトリー市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の二重染色フローサイトメトリー市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「全自動」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

二重染色フローサイトメトリーのグローバル主要企業は、Nexcelom、Logos Biosystems、Thermo Fisher Scientific、Bio-Rad、Beckman Coulter、Merck Millipore、Roche、Olympus、ChemoMetec、Advanced Instruments、Corning、Oxford Optronix、DeNovix、Countstar (ALIT Life Sciences)、NanoEntekなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、二重染色フローサイトメトリーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の二重染色フローサイトメトリー市場：タイプ別、2018年-2023年、2024年-2029年
世界の二重染色フローサイトメトリー市場：タイプ別市場シェア、2022年
・全自動、半自動

世界の二重染色フローサイトメトリー市場：用途別、2018年-2023年、2024年-2029年
世界の二重染色フローサイトメトリー市場：用途別市場シェア、2022年
・病院&診断研究所、製薬&バイオテクノロジー、研究機関、その他

世界の二重染色フローサイトメトリー市場：地域・国別、2018年-2023年、2024年-2029年
世界の二重染色フローサイトメトリー市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における二重染色フローサイトメトリーのグローバル売上、2018年-2023年
・主要企業における二重染色フローサイトメトリーのグローバル売上シェア、2022年
・主要企業における二重染色フローサイトメトリーのグローバル販売量、2018年-2023年
・主要企業における二重染色フローサイトメトリーのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Nexcelom、Logos Biosystems、Thermo Fisher Scientific、Bio-Rad、Beckman Coulter、Merck Millipore、Roche、Olympus、ChemoMetec、Advanced Instruments、Corning、Oxford Optronix、DeNovix、Countstar (ALIT Life Sciences)、NanoEntek

*************************************************************

・調査・分析レポートの概要
二重染色フローサイトメトリー市場の定義
市場セグメント
世界の二重染色フローサイトメトリー市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の二重染色フローサイトメトリー市場規模
世界の二重染色フローサイトメトリー市場規模：2022年 VS 2029年
世界の二重染色フローサイトメトリー市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの二重染色フローサイトメトリーの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の二重染色フローサイトメトリー製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：全自動、半自動
二重染色フローサイトメトリーのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院&診断研究所、製薬&バイオテクノロジー、研究機関、その他
二重染色フローサイトメトリーの用途別グローバル売上・予測

・地域別市場分析
地域別二重染色フローサイトメトリー市場規模 2022年と2029年
地域別二重染色フローサイトメトリー売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Nexcelom、Logos Biosystems、Thermo Fisher Scientific、Bio-Rad、Beckman Coulter、Merck Millipore、Roche、Olympus、ChemoMetec、Advanced Instruments、Corning、Oxford Optronix、DeNovix、Countstar (ALIT Life Sciences)、NanoEntek
...

The Dual Fluorescence Cytometer is a major leap forward in automated cell counting and cell viability analysis. Dual fluorescent cell counters give you sensitive and accurate live/dead cell counts regardless of cell type.
This report aims to provide a comprehensive presentation of the global market for Dual Fluorescence Cytometry Viability Analyzer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Fluorescence Cytometry Viability Analyzer. This report contains market size and forecasts of Dual Fluorescence Cytometry Viability Analyzer in global, including the following market information:
Global Dual Fluorescence Cytometry Viability Analyzer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dual Fluorescence Cytometry Viability Analyzer Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dual Fluorescence Cytometry Viability Analyzer companies in 2022 (%)
The global Dual Fluorescence Cytometry Viability Analyzer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Fully Automatic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dual Fluorescence Cytometry Viability Analyzer include Nexcelom, Logos Biosystems, Thermo Fisher Scientific, Bio-Rad, Beckman Coulter, Merck Millipore, Roche, Olympus and ChemoMetec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dual Fluorescence Cytometry Viability Analyzer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Dual Fluorescence Cytometry Viability Analyzer Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dual Fluorescence Cytometry Viability Analyzer Market Segment Percentages, by Type, 2022 (%)
Fully Automatic
Semi-Automatic
Global Dual Fluorescence Cytometry Viability Analyzer Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dual Fluorescence Cytometry Viability Analyzer Market Segment Percentages, by Application, 2022 (%)
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology
Research Institutes
Others
Global Dual Fluorescence Cytometry Viability Analyzer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dual Fluorescence Cytometry Viability Analyzer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dual Fluorescence Cytometry Viability Analyzer revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dual Fluorescence Cytometry Viability Analyzer revenues share in global market, 2022 (%)
Key companies Dual Fluorescence Cytometry Viability Analyzer sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dual Fluorescence Cytometry Viability Analyzer sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nexcelom
Logos Biosystems
Thermo Fisher Scientific
Bio-Rad
Beckman Coulter
Merck Millipore
Roche
Olympus
ChemoMetec
Advanced Instruments
Corning
Oxford Optronix
DeNovix
Countstar (ALIT Life Sciences)
NanoEntek
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dual Fluorescence Cytometry Viability Analyzer, market overview.
Chapter 2: Global Dual Fluorescence Cytometry Viability Analyzer market size in revenue and volume.
Chapter 3: Detailed analysis of Dual Fluorescence Cytometry Viability Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dual Fluorescence Cytometry Viability Analyzer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dual Fluorescence Cytometry Viability Analyzer capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dual Fluorescence Cytometry Viability Analyzer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dual Fluorescence Cytometry Viability Analyzer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dual Fluorescence Cytometry Viability Analyzer Overall Market Size
2.1 Global Dual Fluorescence Cytometry Viability Analyzer Market Size: 2022 VS 2029
2.2 Global Dual Fluorescence Cytometry Viability Analyzer Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dual Fluorescence Cytometry Viability Analyzer Sales: 2018-2029
3 Company Landscape
3.1 Top Dual Fluorescence Cytometry Viability Analyzer Players in Global Market
3.2 Top Global Dual Fluorescence Cytometry Viability Analyzer Companies Ranked by Revenue
3.3 Global Dual Fluorescence Cytometry Viability Analyzer Revenue by Companies
3.4 Global Dual Fluorescence Cytometry Viability Analyzer Sales by Companies
3.5 Global Dual Fluorescence Cytometry Viability Analyzer Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dual Fluorescence Cytometry Viability Analyzer Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dual Fluorescence Cytometry Viability Analyzer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dual Fluorescence Cytometry Viability Analyzer Players in Global Market
3.8.1 List of Global Tier 1 Dual Fluorescence Cytometry Viability Analyzer Companies
3.8.2 List of Global Tier 2 and Tier 3 Dual Fluorescence Cytometry Viability Analyzer Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Market Size Markets, 2022 & 2029
4.1.2 Fully Automatic
4.1.3 Semi-Automatic
4.2 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Revenue & Forecasts
4.2.1 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2023
4.2.2 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Revenue, 2024-2029
4.2.3 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Revenue Market Share, 2018-2029
4.3 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Sales & Forecasts
4.3.1 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2023
4.3.2 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Sales, 2024-2029
4.3.3 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Sales Market Share, 2018-2029
4.4 By Type – Global Dual Fluorescence Cytometry Viability Analyzer Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Market Size, 2022 & 2029
5.1.2 Hospitals & Diagnostic Laboratories
5.1.3 Pharmaceutical & Biotechnology
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Revenue & Forecasts
5.2.1 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2023
5.2.2 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Revenue, 2024-2029
5.2.3 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Revenue Market Share, 2018-2029
5.3 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Sales & Forecasts
5.3.1 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2023
5.3.2 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Sales, 2024-2029
5.3.3 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Sales Market Share, 2018-2029
5.4 By Application – Global Dual Fluorescence Cytometry Viability Analyzer Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Market Size, 2022 & 2029
6.2 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Revenue & Forecasts
6.2.1 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2023
6.2.2 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Revenue, 2024-2029
6.2.3 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Revenue Market Share, 2018-2029
6.3 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Sales & Forecasts
6.3.1 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2023
6.3.2 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Sales, 2024-2029
6.3.3 By Region – Global Dual Fluorescence Cytometry Viability Analyzer Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2029
6.4.2 By Country – North America Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2029
6.4.3 US Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.4.4 Canada Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.4.5 Mexico Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2029
6.5.2 By Country – Europe Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2029
6.5.3 Germany Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5.4 France Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5.5 U.K. Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5.6 Italy Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5.7 Russia Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5.8 Nordic Countries Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.5.9 Benelux Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2029
6.6.2 By Region – Asia Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2029
6.6.3 China Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.6.4 Japan Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.6.5 South Korea Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.6.6 Southeast Asia Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.6.7 India Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2029
6.7.2 By Country – South America Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2029
6.7.3 Brazil Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.7.4 Argentina Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dual Fluorescence Cytometry Viability Analyzer Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dual Fluorescence Cytometry Viability Analyzer Sales, 2018-2029
6.8.3 Turkey Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.8.4 Israel Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.8.5 Saudi Arabia Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
6.8.6 UAE Dual Fluorescence Cytometry Viability Analyzer Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Nexcelom
7.1.1 Nexcelom Company Summary
7.1.2 Nexcelom Business Overview
7.1.3 Nexcelom Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.1.4 Nexcelom Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.1.5 Nexcelom Key News & Latest Developments
7.2 Logos Biosystems
7.2.1 Logos Biosystems Company Summary
7.2.2 Logos Biosystems Business Overview
7.2.3 Logos Biosystems Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.2.4 Logos Biosystems Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.2.5 Logos Biosystems Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.3.4 Thermo Fisher Scientific Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Bio-Rad
7.4.1 Bio-Rad Company Summary
7.4.2 Bio-Rad Business Overview
7.4.3 Bio-Rad Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.4.4 Bio-Rad Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.4.5 Bio-Rad Key News & Latest Developments
7.5 Beckman Coulter
7.5.1 Beckman Coulter Company Summary
7.5.2 Beckman Coulter Business Overview
7.5.3 Beckman Coulter Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.5.4 Beckman Coulter Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.5.5 Beckman Coulter Key News & Latest Developments
7.6 Merck Millipore
7.6.1 Merck Millipore Company Summary
7.6.2 Merck Millipore Business Overview
7.6.3 Merck Millipore Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.6.4 Merck Millipore Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.6.5 Merck Millipore Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.7.4 Roche Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Olympus
7.8.1 Olympus Company Summary
7.8.2 Olympus Business Overview
7.8.3 Olympus Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.8.4 Olympus Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.8.5 Olympus Key News & Latest Developments
7.9 ChemoMetec
7.9.1 ChemoMetec Company Summary
7.9.2 ChemoMetec Business Overview
7.9.3 ChemoMetec Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.9.4 ChemoMetec Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.9.5 ChemoMetec Key News & Latest Developments
7.10 Advanced Instruments
7.10.1 Advanced Instruments Company Summary
7.10.2 Advanced Instruments Business Overview
7.10.3 Advanced Instruments Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.10.4 Advanced Instruments Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.10.5 Advanced Instruments Key News & Latest Developments
7.11 Corning
7.11.1 Corning Company Summary
7.11.2 Corning Dual Fluorescence Cytometry Viability Analyzer Business Overview
7.11.3 Corning Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.11.4 Corning Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.11.5 Corning Key News & Latest Developments
7.12 Oxford Optronix
7.12.1 Oxford Optronix Company Summary
7.12.2 Oxford Optronix Dual Fluorescence Cytometry Viability Analyzer Business Overview
7.12.3 Oxford Optronix Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.12.4 Oxford Optronix Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.12.5 Oxford Optronix Key News & Latest Developments
7.13 DeNovix
7.13.1 DeNovix Company Summary
7.13.2 DeNovix Dual Fluorescence Cytometry Viability Analyzer Business Overview
7.13.3 DeNovix Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.13.4 DeNovix Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.13.5 DeNovix Key News & Latest Developments
7.14 Countstar (ALIT Life Sciences)
7.14.1 Countstar (ALIT Life Sciences) Company Summary
7.14.2 Countstar (ALIT Life Sciences) Business Overview
7.14.3 Countstar (ALIT Life Sciences) Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.14.4 Countstar (ALIT Life Sciences) Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.14.5 Countstar (ALIT Life Sciences) Key News & Latest Developments
7.15 NanoEntek
7.15.1 NanoEntek Company Summary
7.15.2 NanoEntek Business Overview
7.15.3 NanoEntek Dual Fluorescence Cytometry Viability Analyzer Major Product Offerings
7.15.4 NanoEntek Dual Fluorescence Cytometry Viability Analyzer Sales and Revenue in Global (2018-2023)
7.15.5 NanoEntek Key News & Latest Developments
8 Global Dual Fluorescence Cytometry Viability Analyzer Production Capacity, Analysis
8.1 Global Dual Fluorescence Cytometry Viability Analyzer Production Capacity, 2018-2029
8.2 Dual Fluorescence Cytometry Viability Analyzer Production Capacity of Key Manufacturers in Global Market
8.3 Global Dual Fluorescence Cytometry Viability Analyzer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dual Fluorescence Cytometry Viability Analyzer Supply Chain Analysis
10.1 Dual Fluorescence Cytometry Viability Analyzer Industry Value Chain
10.2 Dual Fluorescence Cytometry Viability Analyzer Upstream Market
10.3 Dual Fluorescence Cytometry Viability Analyzer Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dual Fluorescence Cytometry Viability Analyzer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 二重染色フローサイトメトリーの世界市場見通し2023年-2029年(Dual Fluorescence Cytometry Viability Analyzer Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

二重染色フローサイトメトリーの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp